Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
America's largest for-profit health system posted better-than-expected Q3 results, but the good news came with a catch. A worsening payer mix — driven by patients losing exchange coverage and shifting to uninsured status — cost HCA roughly $400 million in adjusted EBITDA this quarter alone. Executives expect 2027 earnings to hold steady with 2026, though Medicaid cuts from the One Big Beautiful Bill Act loom large.
America's largest for-profit health system, HCA Healthcare, kicked off earnings season with Q3 revenues of $19.85 billion and earnings of $7.22 per diluted share — both topping analyst expectations and year-ago figures. CEO Sam Hazen struck a cautiously optimistic tone, saying HCA is on track to land in the upper half of its 2026 guidance range and expects 2027 performance to be "generally consistent" with this year.
But the fine print tempered the celebration. The expiration of enhanced ACA exchange subsidies has pushed patients off insurance rolls and into uninsured status at a near one-to-one rate, dragging uninsured volumes from 8.5% of admissions in 2025 to 10.5% in 2026. Elective surgical volumes also slipped, with inpatient and outpatient same-facility procedures down 1.4% and 3.7% year-over-year, respectively.
By the Numbers:
Why it matters: HCA's results serve as a bellwether for the broader for-profit hospital sector. The persistent shift toward uninsured patients — fueled by policy-driven coverage losses — signals systemic financial pressure that could ripple across health systems nationwide heading into 2027.
